Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01859780 · ClinicalTrials.gov registry record · NA
Visual Distraction as a Means of Enhancing Child Resistance
A NA study of Unintentional Ingestion of Prescriptions Within Vials and Blisters, sponsored by Michigan State University.
- Completed
- Registry status
- NA
- Development phase
- 229
- Enrollment target
- 3
- Study locations
NCT01859780: Completed NA study of Unintentional Ingestion of Prescriptions Within Vials and Blisters, sponsored by Michigan State University.
NCT01859780 is a NA study of Unintentional Ingestion of Prescriptions Within Vials and Blisters that has completed, run by Michigan State University. The registered enrollment target is 229 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01859780, a NA study of Unintentional Ingestion of Prescriptions Within Vials and Blisters, has completed, sponsored by Michigan State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 229 participants
- Enrollment target
- 3
- Study locations
Study Summary
Unintentional poisonings of children continues to be a major issue in the US. According to a study conducted by Cincinnati Children's Hospital Medical Centers, during the period from 2001-2008, emergency room visits for children less than 5 rose 28% as the result of pharmaceutical products. The authors note, "the problem of pediatric medication poisoning is getting worse, not better." Child resistant closures have been required on most medications sold in the US since the early 1970s. However, most designs attempt to thwart children through purely physical means (e.g. simultaneous dissimilar motion or opening using sequential tasks). Few, if any designs, have utilized perception and cognition as a way to enhance child resistance. The investigators propose utilizing visual illusions in spaces distinct from the opening mechanism of prescription packages as a means of enhancing child resistance. In this project, visual illusion images are applied to both vials and wallet blisters in order to attract children's interest and prolong the time before opening. During Stage I, the investigators will determine if the visual distractor attracts attention when samples are displayed in a storage rack. During Stage II, the investigators will test the effect of visual distractors on child resistance as measured by successful openings and time to open.
Primary Outcome
Selection of one of three treatments in stage one testing (categorical variable)
Conditions Studied
Interventions
- OTHER Visual distractor
Study Locations (3)
Michigan
- Packaging Building - East Lansing
- LESA Early Childhood Programs - Howell
Ohio
- Great Lakes Marketing - Toledo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 229 participants |
| Start Date | 2013-08 |
| Est. Completion | 2015-04 |
| Phase | NA |
What the finished NCT01859780 record still lists
NCT01859780 is an interventional study that assigns participants to a tested intervention. The registered 229 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Unintentional Ingestion of Prescriptions Within Vials and Blisters appearing as the primary indexed condition, and to 1 intervention - of which Visual distractor is the first listed.
NCT01859780 reports a single indexed study location in Michigan, Ohio.
Frequently Asked Questions
What is clinical trial NCT01859780 about?
NCT01859780 is a clinical study titled "Visual Distraction as a Means of Enhancing Child Resistance". Unintentional poisonings of children continues to be a major issue in the US. According to a study conducted by Cincinnati Children's Hospital Medical Centers, during the period from 2001-2008, emergency room visits for children less than 5 rose 28% as the result of pharmaceutical products. The auth...
What is the current status of trial NCT01859780?
This trial is currently completed. It is a NA study. The enrollment target is 229 participants. The study started on 2013-08. Estimated completion is 2015-04.
What conditions does trial NCT01859780 study?
This clinical trial studies the following conditions: Unintentional Ingestion of Prescriptions Within Vials and Blisters.
What interventions are being tested in trial NCT01859780?
The interventions under investigation include: Visual distractor (OTHER).
Who is sponsoring clinical trial NCT01859780?
This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01859780 being conducted?
This trial has 3 study locations across Michigan, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01859780's enrollment target sits among peer trials
229 468th of 2000 higher than 1,533 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02710253 · 230 participants · Phase 2
Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy
- NCT02777879 · 230 participants
Lung Microbiome and Inflammation in Early COPD
- NCT03824483 · 230 participants · Phase 2
Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)
- NCT03833622 · 230 participants · NA
Shared Decision Making to Improve Goals of Care in the ED
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia